在左心病和慢性右心室衰竭中肺高血压
HangYu Watson1, Bansari Patel2, Marco Caccamo2
1Department of Medicine, West Virginia University, Morgantown, WV, USA.
由于左心病 (PH-LHD) 的肺高血压是复杂的,往往导致右心室衰竭. 目前的PH疗法显示有效性有限,需要研究PH-LHD的新干预措施.
科学领域:
- 心脏病学 心脏病学
- 肺部病理学 肺部病理学
- 心脏衰竭研究研究
背景情况:
- 由于左心病 (PH-LHD) 的肺高血压呈现左心房压力升高,导致毛囊后肺高血压.
- 根据肺血管阻力,PH-LHD被分为分离的毛囊后PH和联合的毛囊后和毛囊前PH.
- 右心室衰竭是常见的并发症,由于增加后负荷,加剧心力衰竭症状.
研究的目的:
- 审查治疗PH-LHD的诊断方法和治疗限制.
- 探索PH-LHD.新兴的基于设备的干预措施.
- 强调需要进一步研究优化PH-LHD的治疗策略和患者选择.
主要方法:
- 诊断PH-LHD是通过右心脏导管验证.
- 在PH-LHD的背景下,评估现有的肺高血压特异性疗法的疗效.
- 对新兴的基于设备的干预措施的审查,包括心房间间的分流装置,肺动脉缩和MitraClip.
主要成果:
- 由于左心脏病引起的肺高血压的特征是左心房压升高,并可能进展到右心室衰竭.
- 标准的肺高血压疗法在治疗PH-LHD时表现出有限的有效性.
- 间冲刺装置,肺动脉变质和MitraClip代表了潜在的新疗法途径.
结论:
- 由于左心病引起的肺高血压,由于其复杂性和当前治疗方法的有效性有限,需要专门的管理.
- 基于设备的干预措施对PH-LHD有希望,但进一步的研究至关重要.
- 最佳的患者选择和进一步的研究对于推进PH-LHD的治疗选择至关重要.
更多相关视频
07:41A Model of Reverse Vascular Remodeling in Pulmonary Hypertension Due to Left Heart Disease by Aortic Debanding in Rats
Published on: March 1, 2022
07:41Induction and Phenotyping of Acute Right Heart Failure in a Large Animal Model of Chronic Thromboembolic Pulmonary Hypertension
Published on: March 17, 2022
相关概念视频
Mitral Regurgitation I: Introduction
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Heart Failure III: Clinical Manifestations
Mitral Stenosis I: Introduction
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
